Literature DB >> 30944249

Dietary unsaturated fat increases HDL metabolic pathways involving apoE favorable to reverse cholesterol transport.

Allyson M Morton1, Jeremy D Furtado1, Carlos O Mendivil1, Frank M Sacks1,2,3.   

Abstract

BACKGROUND: HDL that contains apolipoprotein E (apoE) is a subspecies especially active in steps in reverse cholesterol transport, a process that brings cholesterol from peripheral cells to the liver. Here, we studied the effect of dietary unsaturated fat compared with carbohydrate on the metabolism of HDL containing apoE.
METHODS: We enrolled 9 adults who were overweight or obese and had below-average HDL-cholesterol in a crossover study of a high-fat diet, primarily unsaturated, and a low-fat, high-carbohydrate diet. A metabolic tracer study was performed after each diet period.
RESULTS: Dietary fat increased the secretion, metabolism, and clearance of HDL subspecies containing apoE. Dietary fat increased the rate of clearance of large cholesterol-rich HDL containing apoE and increased their conversion to small HDL containing apoE, indicating selective cholesterol ester delivery to the liver. The high-unsaturated-fat diet did not affect the metabolism of HDL lacking apoE.
CONCLUSION: HDL containing apoE is a diet-responsive metabolic pathway that renders HDL more biologically active in reverse cholesterol transport. This may be a mechanism by which unsaturated fat protects against coronary heart disease. Protein-based HDL subspecies such as HDL containing apoE may be used to identify additional atheroprotective treatment targets not evident in the total HDL-cholesterol measurement. TRIAL REGISTRATION: ClinicalTrials.gov NCT01399632. FUNDING: NIH and the National Center for Advancing Translational Science.

Entities:  

Keywords:  Lipoproteins; Metabolism

Mesh:

Substances:

Year:  2019        PMID: 30944249      PMCID: PMC6483656          DOI: 10.1172/jci.insight.124620

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  39 in total

1.  Interaction of plasma lipoproteins containing apolipoproteins B and E with heparin and cell surface receptors.

Authors:  R W Mahley; K H Weisgraber; T L Innerarity
Journal:  Biochim Biophys Acta       Date:  1979-10-26

2.  Pathway of biogenesis of apolipoprotein E-containing HDL in vivo with the participation of ABCA1 and LCAT.

Authors:  Kyriakos E Kypreos; Vassilis I Zannis
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

3.  SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies.

Authors:  P H Barrett; B M Bell; C Cobelli; H Golde; A Schumitzky; P Vicini; D M Foster
Journal:  Metabolism       Date:  1998-04       Impact factor: 8.694

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  Receptor binding of cholesterol-induced high-density lipoproteins containing predominantly apoprotein E to cultured fibroblasts with mutations at the low-density lipoprotein receptor locus.

Authors:  T L Innerarity; R E Pitas; R W Mahley
Journal:  Biochemistry       Date:  1980-09-02       Impact factor: 3.162

6.  Dietary restriction of saturated fat and cholesterol decreases HDL ApoA-I secretion.

Authors:  W Vélez-Carrasco; A H Lichtenstein; F K Welty; Z Li; S Lamon-Fava; G G Dolnikowski; E J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-04       Impact factor: 8.311

7.  Putting cholesterol in its place: apoE and reverse cholesterol transport.

Authors:  Robert W Mahley; Yadong Huang; Karl H Weisgraber
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

8.  Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions.

Authors:  Chunyu Zheng; Christina Khoo; Katsunori Ikewaki; Frank M Sacks
Journal:  J Lipid Res       Date:  2007-02-21       Impact factor: 5.922

9.  Apolipoprotein A-I, A-II, and VLDL-B-100 metabolism in men: comparison of a low-fat diet and a high-monounsaturated fatty acid diet.

Authors:  Sophie Desroches; Marie-Eve Paradis; Mélanie Pérusse; W Roodly Archer; Jean Bergeron; Patrick Couture; Nathalie Bergeron; Benoît Lamarche
Journal:  J Lipid Res       Date:  2004-09-01       Impact factor: 5.922

10.  Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors.

Authors:  D Y Hui; T L Innerarity; R W Mahley
Journal:  J Biol Chem       Date:  1981-06-10       Impact factor: 5.157

View more
  14 in total

1.  Effects of Replacing Dietary Monounsaturated Fat With Carbohydrate on HDL (High-Density Lipoprotein) Protein Metabolism and Proteome Composition in Humans.

Authors:  Allison B Andraski; Sasha A Singh; Lang Ho Lee; Hideyuki Higashi; Nathaniel Smith; Bo Zhang; Masanori Aikawa; Frank M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-09-26       Impact factor: 8.311

2.  Protein-Defined Subspecies of HDLs (High-Density Lipoproteins) and Differential Risk of Coronary Heart Disease in 4 Prospective Studies.

Authors:  Frank M Sacks; Liang Liang; Jeremy D Furtado; Tianxi Cai; W Sean Davidson; Zeling He; Robyn L McClelland; Eric B Rimm; Majken K Jensen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-09-10       Impact factor: 8.311

Review 3.  HDL therapy today: from atherosclerosis, to stent compatibility to heart failure.

Authors:  C R Sirtori; M Ruscica; L Calabresi; G Chiesa; R Giovannoni; J J Badimon
Journal:  Ann Med       Date:  2019 Nov - Dec       Impact factor: 4.709

Review 4.  The HDL Proteome Watch: Compilation of studies leads to new insights on HDL function.

Authors:  W Sean Davidson; Amy S Shah; Hannah Sexmith; Scott M Gordon
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2021-11-18       Impact factor: 4.698

5.  Association Between Gestational Diabetes Mellitus and the Risks of Type-Specific Cardiovascular Diseases.

Authors:  Yuanyuan Mao; Wenbin Hu; Bin Xia; Li Liu; Xia Han; Qin Liu
Journal:  Front Public Health       Date:  2022-07-05

Review 6.  The Difference Between High Density Lipoprotein Subfractions and Subspecies: an Evolving Model in Cardiovascular Disease and Diabetes.

Authors:  W Sean Davidson; Allison L Cooke; Debi K Swertfeger; Amy S Shah
Journal:  Curr Atheroscler Rep       Date:  2021-03-27       Impact factor: 5.113

7.  ApoE and apoC-III-defined HDL subtypes: a descriptive study of their lecithin cholesterol acyl transferase and cholesteryl ester transfer protein content and activity.

Authors:  Mateo Amaya-Montoya; Jairo A Pinzón-Cortés; Lina S Silva-Bermúdez; Daniel Ruiz-Manco; Maria C Pérez-Matos; Mario A Jiménez-Mora; Carlos O Mendivil
Journal:  Lipids Health Dis       Date:  2020-05-25       Impact factor: 3.876

8.  Comparison of Plasma Lipoprotein Composition and Function in Cerebral Amyloid Angiopathy and Alzheimer's Disease.

Authors:  Anna Bonaterra-Pastra; Sofia Fernández-de-Retana; Andrea Rivas-Urbina; Núria Puig; Sònia Benítez; Olalla Pancorbo; David Rodríguez-Luna; Francesc Pujadas; Maria Del Mar Freijo; Silvia Tur; Maite Martínez-Zabaleta; Pere Cardona Portela; Rocío Vera; Lucia Lebrato-Hernández; Juan F Arenillas; Soledad Pérez-Sánchez; Joan Montaner; Jose Luis Sánchez-Quesada; Mar Hernández-Guillamon
Journal:  Biomedicines       Date:  2021-01-12

9.  Cerebrovascular amyloid Angiopathy in bioengineered vessels is reduced by high-density lipoprotein particles enriched in Apolipoprotein E.

Authors:  Jerome Robert; Emily B Button; Emma M Martin; Luke McAlary; Zoe Gidden; Megan Gilmour; Guilaine Boyce; Tara M Caffrey; Andrew Agbay; Amanda Clark; Judith M Silverman; Neil R Cashman; Cheryl L Wellington
Journal:  Mol Neurodegener       Date:  2020-03-25       Impact factor: 14.195

10.  The PPAR pan-agonist tetradecylthioacetic acid promotes redistribution of plasma cholesterol towards large HDL.

Authors:  Thomas Lundåsen; Matteo Pedrelli; Bodil Bjørndal; Björn Rozell; Raoul V Kuiper; Lena Burri; Chiara Pavanello; Marta Turri; Jon Skorve; Rolf K Berge; Stefan E H Alexson; Veronika Tillander
Journal:  PLoS One       Date:  2020-03-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.